Keywords: pfizer, buy, encysive, 195m, gains, thelin, world
Pfizer to buy Encysive for $195M, gains Thelin
Article | 25 February 2008
World drug giant Pfizer has entered into an agreement to acquire fellow USA-based Encysive Pharmaceuticals, a publicly-held drugmaker whose pulmonary ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
